A launch decision combines regulatory feasibility with a workable commercial and supply plan. Define your target customer channels, expected demand assumptions and the proposed reimbursement route. Separate evidence from estimates. A market-size figure alone does not establish achievable sales, and a directory of approved medicines is not a complete demand forecast.
Questions to resolve with your Swiss partner
Review the practical route from product availability to a customer order. Who manages ordering, medical information, returns and complaints? What costs are fixed and what varies with sales or shipments? Build scenarios for delayed reimbursement, a slower launch and unexpected supply costs. These questions help frame a specialist discussion without pretending that an online checklist can validate the business case.
- State customer channels and the basis for demand assumptions.
- Separate product authorisation from reimbursement and pricing decisions.
- Map order handling, customer support and supply dependencies.
- Discuss cost drivers and delayed-launch scenarios with the proposed partners.
This independent resource helps pharmaceutical businesses prepare questions for appropriately qualified providers. It is not a regulator, licence holder or substitute for product-specific regulatory advice. Official publications and the applicable legislation take precedence. No authorisation outcome, provider availability, fee or completion date is guaranteed.
Readiness checklist →